SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-068309
Filing Date
2023-08-16
Accepted
2023-08-16 17:27:03
Documents
15
Period of Report
2023-08-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea183751-8k_longeveron.htm   iXBRL 8-K 39161
2 PRESS RELEASE OF LONGEVERON INC., DATED AUGUST 16, 2023, ANNOUNCING REGISTRATION ea183751ex99-1_longeveron.htm EX-99.1 25171
7 GRAPHIC ex99-1_001.jpg GRAPHIC 3146
  Complete submission text file 0001213900-23-068309.txt   294367

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE lgvn-20230816.xsd EX-101.SCH 3766
4 XBRL DEFINITION FILE lgvn-20230816_def.xml EX-101.DEF 26610
5 XBRL LABEL FILE lgvn-20230816_lab.xml EX-101.LAB 36661
6 XBRL PRESENTATION FILE lgvn-20230816_pre.xml EX-101.PRE 25234
9 EXTRACTED XBRL INSTANCE DOCUMENT ea183751-8k_longeveron_htm.xml XML 5260
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

IRS No.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40060 | Film No.: 231179159
SIC: 2834 Pharmaceutical Preparations